Amoéba publishes its 2025 Universal Registration Document

On March 18, 2026, Amoéba, a company specializing in natural microbiological solutions, announced the public availability of its 2025 Universal Registration Document. This document, filed with the Financial Markets Authority under number D.26-0108, includes the annual financial report, the consolidated and annual accounts, and the corporate governance report.

Amoéba, listed on Euronext Growth, specializes in the use of amoebae for biocontrol and cosmetic applications. It has obtained significant marketing authorizations in the United States and Europe for its biocontrol products. The document is available on the company's website in the investor relations section.